APO-501
| Code | Size | Price |
|---|
| TAR-T30100-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
APO-501 is a bioactive chemical.
CAS:
242487-05-4
Formula:
C14H22N4O4S
Molecular Weight:
342.41
Purity:
0.98
SMILES:
COc1nsc(N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(O)=O)n1
References
1. Hara H, Maeda A, Kamiya T, Adachi T. Protective effects of apomorphine against zinc-induced neurotoxicity in cultured cortical neurons. Biol Pharm Bull. 2013;36(4):585-91. PubMed PMID: 23546293.
2. Byrne DP, Manandhar SP, Potempa J, Smalley JW. Breakdown of albumin and haemalbumin by the cysteine protease interpain A, an albuminase of Prevotella intermedia. BMC Microbiol. 2015 Sep 24;15:185. doi: 10.1186/s12866-015-0516-3. PubMed PMID: 26403890; PubMed Central PMCID: PMC4582931.
3. Harwood DG, Barker WW, Ownby RL, St George-Hyslop P, Duara R. Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. Am J Geriatr Psychiatry. 1999 Spring;7(2):119-23. PubMed PMID: 10322238.
4. Cho S, Moon H, Loh TJ, Jang HN, Liu Y, Zhou J, Ohn T, Zheng X, Shen H. Splicing inhibition of U2AF65 leads to alternative exon skipping. Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9926-31. doi: 10.1073/pnas.1500639112. Epub 2015 Jul 27. PubMed PMID: 26216990; PubMed Central PMCID: PMC4538632.